Malignant pleural mesothelioma: new guidelines make us stronger for defeating this disease.

Remon, J; Hendriks, L E L; Bironzo, P

Remon, J; Hendriks, L E L; Bironzo, P.

Afiliación

Remon J; Department of Medical Oncology, Centro Integral Oncológico Clara Campal (HM-CIOCC), Hospital HM Nou Delfos, HM Hospitales, Barcelona, Spain. Electronic address: jremon@hmhospitales.com.
Hendriks LEL; Department of Respiratory Medicine, Maastricht University Medical Centre, GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands.
Bironzo P; Department of Oncology, University of Torino, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Ann Oncol ; 33(2): 123-125, 2022 02.

Article en En | MEDLINE | ID: mdl-34883215

Asunto(s)

Mesotelioma Maligno; Mesotelioma; Neoplasias Pleurales; Humanos; Mesotelioma/epidemiología; Mesotelioma/patología; Mesotelioma/terapia; Neoplasias Pleurales/patología; Neoplasias Pleurales/terapia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pleurales / Mesotelioma Maligno / Mesotelioma Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google